GlassScriptPhysician profile
Rosemary Mccarthy
NPI 1750578613
$547.14
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $144 · 2022: $115 · 2023: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $143.60 | 2019 | |
| Gynesonics, INC. | $84.02 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $48.01 | 2021 | |
| Therapeuticsmd, INC. | $44.75 | 2021-2022 | |
| Exeltis, USA INC. | $40.86 | 2021 | |
| Conmed Corporation | $34.23 | 2022 | |
| Organon LLC | $28.21 | 2021-2023 | Nexplanon |
| Smith+Nephew, INC. | $19.58 | 2022 | |
| Hologic Sales and Service, LLC | $17.61 | 2022 | |
| Davol INC. | $17.12 | 2019 | |
| Meditrina | $16.62 | 2023 | |
| Baxter Healthcare | $13.76 | 2022 | |
| Medtronic, INC. | $13.28 | 2022 | |
| Allergan, INC. | $13.13 | 2019 | |
| Avion Pharmaceuticals | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosemary Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.